secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIZYME, INC. (—)
CIK:        0001413754
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0001493152-23-018164
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 1.01, 2.03, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marizyme closes $1M initial tranche of $10M private placement; files 1-for-15 forward stock split
--------------------------------------------------------------------------------

- Initial closing: Walleye invested $1M for 11,764,710 units; net proceeds $870K after fees.
- Each unit: 15% OID convertible note (principal $1,176,471, conversion $0.10) plus two warrants at $0.10 and $0.20 per share.
- Sixth Certificate of Change (May 15) increases authorized common stock from 20M to 300M shares and effects 1-for-15 forward split.
- Placement agent Univest receives 8% cash fee, expense reimbursement up to $200K, and 8% warrant coverage.
- Convertible notes mature in 9 months, bear 10% interest, and are subordinated to senior debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1413754/000149315223018164/0001493152-23-018164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1413754/000149315223018164/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-018164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer